The 17th Sustainable Development Goal seeks to promote partnerships at various levels To this end, COVID-19 vaccines development partnerships in the BRICS (Brazil, Russia, India, China and South Africa) are inevitable in facilitating ethical access to affordable and safe vaccines the world over With South Africa being part of the BRICS, its presence can assist in leveraging the partnership to ensure that COVID-19 vaccines developed by the BRICS are efficiently deployed in Africa Through the tracking of announcements, documents and critical discourse analysis, and Geographical Information Systems, this paper investigates COVID-19 vaccines development collaboration in the BRICS and its implication for Africa It emerges that there is an inherent discord in the BRICS, with bilateral arrangements both within and outside the forum being evident This has resulted in advance breakthrough COVID-19 vaccines from China and Russia not widely tried across the BRICS The paper notes that these developments weaken the global south and affect its potential to develop COVID 19 vaccines The work recommends a reconsideration in terms of COVID-19 vaccines development and future proofing of collaboration within the BRICS and finding a way of having South Africa continue to lobby for affordable and accessible vaccines for Africa [ABSTRACT FROM AUTHOR] Copyright of Politikon: South African Journal of Political Studies is the property of Routledge and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission However, users may print, download, or email articles for individual use This abstract may be abridged No warranty is given about the accuracy of the copy Users should refer to the original published version of the material for the full abstract (Copyright applies to all Abstracts )

https://www.tandfonline.com/doi/pdf/10.1080/02589346.2021.1913797

COVID-19 Vaccines Development Discord: A Focus on the BRICS and Implications for Africa’s Access and Affordability Matters

Since the emergence of COVID-19 in Wuhan China in early 2019, the global spread of this virus has impacted markets, health systems and general households across the world. Even with draconian containment measures, such as monitored movement restrictions, closed borders and the various lockdowns, the disease has appeared highly difficult to contain. Within a few months, it reached all BRICS countries, affecting more than 39.7 million people, which accounts for 26.3 percent of global infections, declaring it a global pandemic by the WHO. Unfortunately, the rapid spread and imposing nature of this virus has not provided countries with enough time and space to reflect on the far-reaching consequences that arise from poor public policy measures as well as disease control measures by their respective health systems. As a result, a lot of dis-ease amongst the public, government policy implementers and health care providers has raised. This has negatively impacted people's day-to-day activities and lives. Increased mortality rates amongst the elderly have been a growing concern as well as the increasing effects on all other age groups across BRICS countries. Using a comparative study approach, this paper seeks to analyse the effects of Covid-19 and the dis-ease that arises from its proximity in BRICS countries. Additionally, the paper will provide a qualitative overview of public policy approaches comparing the member countries, and addressing the effects of this pandemic and the dis-ease it has caused amongst BRICS countries. 

pdf/disease-and-dis-ease-amid-covid-19-3z1wsj040e.pdf

Disease and Dis-Ease amid Covid-19

With the perspicuous effect of COVID-19 on vaccine demand, academic and business interest in vaccine production in the BRICS nations (Brazil, the Russian Federation, India, China, and South Africa) has reached a crescendo. Aware of a “dark” past when the BRICS depended heavily on vaccines and pharmaceuticals from other parts of the world, academic curiosity on how the BRICS countries have leveraged vaccine self-sufficiency and become the hub of global vaccine production and supply is justifiable, especially in times of ineffable pandemics.The articles were searched from November 2020 to December 2022. Within this period, an electronic search of 13 reputable healthcare and public databases was conducted. The initial searches from the designated databases yielded a total of 3,928 articles. Then, duplicated studies were removed through a two-step process, articles without titles and abstracts were excluded, and the remaining 898 articles that met the qualification assessment criteria were evaluated for article quality.The main entrepreneurial innovations that have quickened the pace of vaccine self-sufficiency in the BRICS include investment in artificial intelligence (AI), Big Data Analytics, and Blockchain technologies. These help to speed up the drug delivery process by enhancing patient identification or optimizing potential drug candidates for clinical trials and production.Over the past 20 years, the BRICS nations have achieved major strides in vaccine development, regulation, and production. The creation of the BRICS Vaccine Research and Development (R&D) Center will have a significant impact on vaccine cost and accessibility given the anticipated development of stronger research capability, production, and distribution technology, as well as stronger standardization to improve vaccine production quality in the near future. It is anticipated that the BRICS’ contributions to vaccine development will alter the global vaccination market and hasten the availability of vaccinations in developing nations. The challenge is turning these hopes into concrete plans of action and outcomes.

On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation

Since late 2019, SARS-CoV2 pandemic has spread worldwide. After several generations without a severe pandemic, the mixture of health and economic crisis has hit populations in all continents. The high degree of connectivity that States share, enabled by the current transportation and communication technologies, caused different regions of the world to be affected by coronavirus disease at almost the same time. Yet States responses to the SARS-CoV2 pandemic were not the same. This brief focuses on the BRICS countries individual, bilateral and collective responses to the international health crisis caused by coronavirus disease, from the early detection of COVID-19 cases in China in late December 2019 to the current surge of cases in Brazil.

/pdf/the-brics-response-to-covid-19-1szapbwvj5.pdf

The BRICS response to COVID-19

Galiellalactone: a review on synthetic strategies and tactics

Handle everyday research tasks with reliable, citation-backed results

Your personal Research Agent to handle research tasks with citation-backed results

Popular Tasks used by Researchers

How can I help with your research?

Meet SciSpace

Get more enhanced response by uploading the PDFs you want me to reference.

No relevant PDFs in your library

SciSpace is the AI research assistant for academics. Run systematic literature reviews on 280M+ papers, and write papers with cited sources. Trusted by 1M+ students, PhDs & researchers.

SciSpace | AI for Research

Analyze PDFs

Code & Manuscripts

Funding & Grants

Literature & Patents

Medical & Clinical Data

Systematic Review

Visualize & Present

Web & Data

Build a Google Scholar-like website for your research.

Build a website

Create charts and images for your research

Create a Chart

Write a paper for submission to a journal

Draft a manuscript

Patent Search

Design eye-catching scientific posters in minutes.

Scientific Poster Generation

Systematic Literature Review

One task is running at the moment. Your messages will be shown right after.

Drag and drop or click here to browse

Loved by <highlight>1 million+</highlight> researchers

Extract a list of specific topics and their sources from unstructured text

Topics

Compare and analyze relevant papers that matches with your search

Papers

Get insights from PDFs and bookmarked papers from your library

My library

Recent searches

Try searching for:

Catch AI-generated content in scholarly and non-scholarly content

{ai} Detector

Ai Writer

Get PDF Summaries, highlighted text explanations 

Chat with PDF

Effortlessly create in-text citations and bibliographies in APA and 2,500 other formats

Citation generator

Get explanations, summaries, and answers on academic papers

Ease up your research workflow with {scispace}'s cohort of exciting AI tools

Elevate your academic writing skills and convey your ideas the way you want

Paraphraser

Explore our range of reading and writing tools

Your file is being prepared and should be ready in a few minutes. If it's a large file, it might take a bit longer. You can close this window, and we'll email you the file when it's done.

You have reached a maximum limit of <strong>{limit}</strong> columns in the table. Remove at least <strong>1</strong> column to add or create another one.

Arindam Das

Author Tools

Chat about Author

Papers

The BRICS response to COVID-19

Galiellalactone: a review on synthetic strategies and tactics